Brian Eater

Director Of Quality Assurance at QED Therapeutics - Palo Alto, CA, US

Brian Eater's Contact Details
HQ
650-231-4088
Location
Company
QED Therapeutics
Brian Eater's Company Details
QED Therapeutics logo, QED Therapeutics contact details

QED Therapeutics

Palo Alto, CA, US • 100 - 249 Employees
BioTech/Drugs

QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.

N/A
Details about QED Therapeutics
Frequently Asked Questions about Brian Eater
Brian Eater currently works for QED Therapeutics.
Brian Eater's role at QED Therapeutics is Director Of Quality Assurance.
Brian Eater's email address is ***@qedtx.com. To view Brian Eater's full email address, please signup to ConnectPlex.
Brian Eater works in the Biotechnology industry.
Brian Eater's colleagues at QED Therapeutics are Yen Nguyen, Andrea Orozco, Adalynn Harris, Ray Villar, Kimberly Richards, Shugufa Afifi, Chelsea Wolfe and others.
Brian Eater's phone number is 650-231-4088
See more information about Brian Eater